A friend of mine texted recently asking about an online post claiming that chemical sunscreens are dangerous — full of "pretty bad chemicals" that end up in your bloodstream. This is a common question I get in clinic. The actual data is more reassuring than the internet would suggest.
The short version: chemical sunscreens are absorbed into the bloodstream. That much is well-established. But the specific number that keeps getting cited as evidence of harm — 0.5 ng/mL — is not a danger threshold. It is a regulatory trigger. The distinction matters.
The Two Categories
Sunscreens fall into two broad classes based on how they work. Mineral (or inorganic) sunscreens use zinc oxide and titanium dioxide as their active ingredients. These sit at or near the surface of the skin and protect by scattering, reflecting, and absorbing ultraviolet radiation. Chemical (or organic) sunscreens use compounds like avobenzone, oxybenzone, octocrylene, homosalate, octisalate, and octinoxate. These absorb UV radiation and dissipate it as a small amount of heat. Both categories reduce UV exposure to the skin — the mechanism for skin cancer prevention — when applied correctly.
What the FDA Studies Showed
In 2019 and 2020, an FDA-sponsored team published two randomized clinical trials in the Journal of the American Medical Association (Matta and colleagues). The 2019 pilot tested four organic filters — avobenzone, oxybenzone, octocrylene, and ecamsule — under maximal-use conditions. The 2020 study expanded to six: avobenzone, oxybenzone, octocrylene, homosalate, octisalate, and octinoxate. All of them exceeded the 0.5 ng/mL plasma concentration threshold — often after a single application. Oxybenzone reached the highest levels, at times more than 250 ng/mL.
That figure — 0.5 ng/mL — has since been widely cited online as if it were a safety limit. It is not. The FDA uses it as a regulatory trigger: if a topical drug produces plasma concentrations above 0.5 ng/mL, the agency requests additional data on things like systemic carcinogenicity and reproductive effects before granting full "generally recognized as safe and effective" (GRASE) status. In other words, exceeding the threshold means we should keep studying the ingredient. It does not mean the ingredient has been shown to be harmful.
One recent update worth noting: in June 2026, the FDA cleared bemotrizinol as a new permitted sunscreen active ingredient in the U.S. When consumer products appear on shelves will depend on manufacturer rollout, but it is a rare regulatory addition to a category that has otherwise been static for years.
What Those Additional Studies Have Shown
Recent reviews of the sunscreen safety literature, including a comprehensive 2025 review in Photodermatology, Photoimmunology & Photomedicine by Kalia, generally conclude that although several organic filters are systemically absorbed and further safety data are appropriate, current human data have not established a causal link between typical sunscreen use and major adverse health outcomes. Systematic reviews of human studies covering fertility, fetal growth, and childhood development have similarly failed to identify a definitive harm signal.
This is not the same as saying the ingredients are perfectly safe forever. It is saying that after decades of use and dozens of studies, we do not have credible evidence of harm.
The Oxybenzone Conundrum
Oxybenzone is the filter that most often comes up as the possible exception, and it is worth being clear about what the concern actually is. In vitro assays show that oxybenzone can weakly bind estrogen and androgen receptors. In rodent studies using oral exposure, it has produced hormone-sensitive changes, including effects on estrous cycles and mammary gland development.
Older dose-gap calculations suggested an enormous margin between the rodent exposures that produced these effects and human topical exposures. A 2023 integrative review by Mustieles and colleagues argued the gap is narrower than it appeared — the pharmacokinetic data from the FDA trials show that whole-body topical application produces peak plasma concentrations that may overlap with concentrations producing endocrine effects in laboratory assays. Human epidemiologic studies have not established a causal relationship between oxybenzone exposure and adverse health outcomes such as fertility, fetal growth, or childhood development, but several observational associations — with thyroid hormones, testosterone levels, menstrual-cycle biomarkers, and reproductive conditions like uterine fibroids — have been reported and remain unresolved.
The FDA's current classification of oxybenzone — "not GRASE due to insufficient data" — is a request for more long-term toxicology data before granting full GRASE status; it is not a safety warning, and the ingredient remains legal to market in the meantime. There is enough uncertainty here that I would not fault anyone for choosing oxybenzone-free formulations. For children, pregnancy, or anyone who prefers to minimize systemic absorption on principle, an oxybenzone-free or mineral-based sunscreen is a reasonable option. The other chemical filters generally show human plasma concentrations well below the levels that produce activity in laboratory assays.
Choosing Certainty
The benefit of sunscreen is apparent. The Nambour Skin Cancer Prevention Trial, a landmark Australian study, remains the strongest randomized evidence: daily sunscreen use was associated with substantially fewer invasive melanomas on long-term follow-up and reduced squamous cell carcinoma tumor burden. Skin cancer is common — one in five Americans will develop it in their lifetime — and sunscreen is one of the most effective tools we have to prevent it.
Sunscreen Is One Tool, Not the Whole Toolbox
It is worth stepping back from the sunscreen debate for a moment and remembering that sunscreen is one component of sun protection, not the entire picture. UV-protective clothing does more of the work than most people realize. A long-sleeved UPF 50+ shirt blocks roughly 98% of UV to the covered skin, does not sweat off, does not need reapplication, and does not raise systemic-absorption concerns. A wide-brimmed hat protects the scalp, ears, and much of the neck — areas people routinely under-apply sunscreen to. UV-blocking sunglasses handle the eyes and lids.
Seeking shade during the peak UV window (roughly 10 AM to 2 PM) and adjusting the timing of outdoor activity are the other free interventions in the toolkit. None of this replaces sunscreen where the skin is exposed. But the question of which sunscreen to use is a subset of a larger question about how to protect your skin over a lifetime. The highest-yield strategy is layered: cover what you can with clothing and shade, and use sunscreen on what remains.
What I Actually Do
For patients who ask, my recommendation is the same as the American Academy of Dermatology's: use a broad-spectrum sunscreen with SPF 30 or higher, apply enough of it, and reapply. Any legally marketed, broad-spectrum U.S. sunscreen — mineral, chemical, or hybrid — is acceptable. Mineral sunscreens are a reasonable first choice for children, pregnancy, or anyone who wants to minimize absorption. For daily use in adults with no specific concern, chemical filters work and are often more cosmetically elegant.
For what it is worth, I use both mineral and chemical sunscreens. As you may have noticed from photos in my posts, I'm a big fan of UPF clothing and sun-protective hats as they are quick and easy to use (not to mention VERY stylish). I combine my UPF outfit with mineral sunscreen on the face for sensitive skin and a spray chemical sunscreen on my legs and hands. Happy hiking!
Disclaimer: This article is general dermatologic education and not medical advice. Individual decisions about sunscreen or any personal care product deserve a conversation with your own physician.
References
Kalia S. The Evolution, Safety, and Public Perception of Sunscreens: A Historical and Contemporary Review. Photodermatol Photoimmunol Photomed. 2025;41(5):e70055.
Matta MK, Zusterzeel R, Pilli NR, et al. Effect of Sunscreen Application Under Maximal Use Conditions on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial. JAMA. 2019;321(21):2082–2091.
Matta MK, Florian J, Zusterzeel R, et al. Effect of Sunscreen Application on Plasma Concentration of Sunscreen Active Ingredients: A Randomized Clinical Trial. JAMA. 2020;323(3):256–267.
American Academy of Dermatology. What to wear to protect skin from the sun. Accessed July 2026.
Green AC, Williams GM, Logan V, Strutton GM. Reduced melanoma after regular sunscreen use: randomized trial follow-up. J Clin Oncol. 2011;29(3):257–263.
Mustieles V, Balogh RK, Axelstad M, et al. Benzophenone-3: Comprehensive review of the toxicological and human evidence with meta-analysis of human biomonitoring studies. Environ Int. 2023;173:107739.